跳至主要内容
临床试验/IRCT20221108056446N9
IRCT20221108056446N9尚未招募3 期

The effectiveness of Citalopramin preventing depression in patients with moderate Traumatic brain injury

Esfahan University of Medical Sciences0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with a consciousness coefficient between 9 and 13
  • Conscious consent of first -degree companions to enter the study
  • Complete recovery from trauma 4 weeks after the incident
  • Patients with a history of mood disorder must be in complete remission for at least 1 year after discontinuation of treatment

排除标准

  • Patients with persistent depression or any other mood disorder based on medical records and doctor's definitive diagnosis
  • Pregnant women or women who plan to become pregnant during the study period
  • Previous history of allergy to Citalopramin
  • Complex and debilitating underlying disease such as cancer, advanced heart failure

研究者

相似试验

Citalopramin preventing depression in moderate TBI | 临床试验